Regulatory Compliance Clarification from RPG Life Sciences
Date and Nature of Exchange Query
RPG Life Sciences Limited received a communication from the National Stock Exchange of India Ltd. on September 23, 2026, referenced under NSE/CM/Surveillance/17595. The query specifically addressed the observed increase in trading volume of the company's shares and sought clarification regarding the reasons behind this movement.
Company's Clarification on Trading Volume
The company, through its Head - Legal & Company Secretary Mr. Rajesh Ramesh Shirambekar, provided a formal response stating that the recent increase in trading volume is "purely attributable to market conditions." The company explicitly stated that it is "not aware of any specific reason for the said movement" beyond general market dynamics.
Regulatory Compliance Disclosure
RPG Life Sciences confirmed full compliance with SEBI regulatory requirements, specifically referencing Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company asserted that "all information required to be disclosed under Regulation 30 has been duly disclosed by the Company from time to time."
Financial Results and Operational Performance Clarification
The company categorically stated that "there is no unpublished event/information/announcement relating to operation/performance of the Company" that requires disclosure to the Stock Exchanges under Regulation 30. This includes any information that "may have a bearing on the price/volume of the Shares of the Company."